FLOWR.root is presented, an SE(3)-equivariant flow-matching framework that jointly generates high-quality 3D ligands and predicts multi-endpoint binding affinities, demonstrating state-of-the-art performance, efficient domain adaptation, and practical impact across de novo design, scaffold elaboration, and lead optimization workflows.
Abstract
We present FLOWR.ROOT, an SE(3)-equivariant flow-matching foundation model that unifies pocket-aware 3D ligand generation with multi-endpoint binding affinity prediction (pIC50, pKi, pKd, pEC50) and pLDDT-based confidence estimation in a single backbone. One trained model supports de novo pocket-conditional generation, interaction- and pharmacophore-conditional sampling, scaffold hopping and elaboration, and fragment growing or replacement, enabled by a mixed isotropic–anisotropic prior placement strategy. Training proceeds in three stages: large-scale pre-training on billions of ligand conformations and millions of mixed-fidelity protein–ligand complexes, refinement on curated co-crystal data, and project-specific adaptation via parameter-efficient LoRA finetuning. Joint structure–affinity modelling enables inference-time importance-sampling guidance for single- and multi-objective design without external scoring functions. Case studies on kinase selectivity (CK2α/CLK3) and scaffold elaboration on TYK2, ERα, and BACE1 illustrate utility from hit identification through lead optimization. Structure-based generative modeling is rapidly reshaping drug discovery by enabling pocket-aware ligand design alongside predictive evaluation of binding properties. This manuscript introduces FLOWR.root, an SE(3)-equivariant flow-matching framework that jointly generates high-quality 3D ligands and predicts multi-endpoint binding affinities, demonstrating state-of-the-art performance, efficient domain adaptation, and practical impact across de novo design, scaffold elaboration, and lead optimization workflows.
Flowr.root achieves state-of-the-art performance in both unconditional 3D molecule and pocket-conditional ligand generation, producing geometrically realistic, low-strain structures with computational efficiency on established benchmark datasets.
Julian Cremer, Tuan Le, M. Ghahremanpour et al.· arXiv.org· 5 citations· ⚡1
A clear pattern is revealed in LLM spatial capabilities: while they still lag behind state-of-the-art approaches, they are promising and can handle multiple spatial constraints simultaneously, enabling scaling to heterogeneous setups.
Thomas MacDougall, Maksim Kuznetsov, Roman Schutski et al.· arXiv.org· 1 citation
Abstract Motivation To enable real-world protein-ligand affinity prediction, not only out-of-distribution generalization but also robustness to variable structural availability and quality should be considered in model design. Results We present AlignNet, a hierarchical representation alignment framework that mitigates...
Xiaowen Hu, Hong-Yi Huang, Hao Sun et al.· Bioinform.· 0 citations
The resulting model, HydrAffinity, is an interaction-free, dynamic sparse model that uses pre-trained encoders and MoE for parameter-efficient learning and outperforms all interaction-free methods and matches state-of-the-art interaction-based methods on CASF-2016.
Structure-based drug design (SBDD) models are central to modern pharmaceutical research, enabling the rational exploration of protein-ligand interactions at atomic resolution. However, most existing approaches frame molecular generation as an isolated optimization or a one-to-one matching task, overlooking the shared b...
Dong Xu, Zhang-Fan Yang, Junchuang Cai et al.· IEEE transactions on computa...· 1 citation
Motivation Ligand binding-site similarity search is a crucial step in drug discovery that reduces the conformational search space for docking and other downstream tasks by comparing a target protein against experimentally identified binding sites. Existing methods rely on either direct structural alignment or lossy com...
Kyunghwan Yeo, Dongwoo Kim, Jaemin Sim et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.